Showing results (61-70 of 443) with videos related to
Sort By:
Pageof 45
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Combining the antimesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cellsKevin Hollevoet, Antonella Antignani, David J Fitzgerald, et al.Proceedings of the National Academy of Sciences of the United States of America|November 21, 2022
Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structuresWenlong Liu, Chin-Hsien Tai, Xiufen Liu, et al.Plos One|March 25, 2015
Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell lineKevin Hollevoet, Emily Mason-Osann, Fabian Müller, et al.Endocrinology|July 17, 2003
Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoterWing-Shing Cheng, Valeria Giandomenico, Ira Pastan, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant ImmunotoxinEmily M King, Ronit Mazor, Nicolas Çuburu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2011
Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapyRajat Singh, Yujian Zhang, Ira Pastan, et al.Oncotarget|November 21, 2017
Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathwayXiu-Fen Liu, Qi Zhou, Raffit Hassan, et al.Receptors & Clinical Investigation|March 14, 2017
EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced deliveryXuhui Bao, Ira Pastan, Darell D Bigner, et al.Molecular Cancer Therapeutics|March 5, 2016
Protein Kinase Inhibitor H89 Enhances the Activity of Pseudomonas Exotoxin A-Based ImmunotoxinsXiufen Liu, Fabian Müller, Alan S Wayne, et al.Bioconjugate Chemistry|March 20, 2003
Mutants of immunotoxin anti-Tac(dsFv)-PE38 with variable number of lysine residues as candidates for site-specific chemical modification. 1. Properties of mutant moleculesMasanori Onda, James J Vincent, Byungkook Lee, et al.Pageof 45